Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it is “poised to lead the charge in AI-driven healthcare solutions” after a strong start to 2023.
"Predictmedix AI is proud to have achieved significant advancements this year, solidifying our position as a leader in AI-driven healthcare solutions,” Rahul Kushwah, COO of Predictmedix said in a statement.
“Our dedication to innovation, validated technology, and strategic partnerships underscores our commitment to revolutionizing patient care and safety on a global scale.”
Over the course of the year, Predictmedix’s Triage Solution now covers 16 vital parameters, enhancing its versatility and accuracy in healthcare settings. The company has gathered data from over 200,000 individuals through AI-powered Safe Entry Stations, contributing to improved machine learning accuracy across healthcare and other sectors. Additionally, Predictmedix introduced non-invasive measurement technology for cardiovascular parameters, innovative diabetes screening methods, and a first-to-market fitness scan using advanced machine learning algorithms.
These technological developments have been independently validated in hospitals and universities in India and Indonesia, solidifying Predictmedix's credibility in healthcare.
In terms of business development, Predictmedix is expanding into Indonesia and the ASEAN region, collaborating with prestigious institutions for tailored research and development. The firm is also capitalizing on India's growing healthcare needs, partnering with government officials and departments.
To streamline operations in India, they have established "Predictmedix India Pvt Ltd" and engaged an Indian supplier for mass production of Safe Entry Stations, enhancing production capacity and accessibility.
Toronto-based Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally.